CA 19-9 as a Predictor of CT Response for Patients With Locally Advanced Pancreatic Cancer (LAPC)

被引：0
|
作者：
Moskovic, D. J. [1 ]
Carlson, P. [1 ]
Dakik, H. [1 ]
Qiao, W. [2 ]
Javle, M. [2 ]
Fogelman, D. R. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
来源：
PANCREAS | 2009年 / 38卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1029 / 1029
页数：1
相关论文
共 50 条
  • [1] Serum CA 19-9 level as a surrogate marker for prognosis in locally advanced pancreatic cancer (LAPC)
    Fogelman, D. R.
    Pathak, P.
    Qiao, W.
    Chadha, R.
    Jhamb, J.
    Melisi, D.
    Wolff, R. A.
    Abbruzzese, J. L.
    Javle, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] CA 19-9 AS A PREDICTOR FOR RESPONSE AND SURVIVAL IN ADVANCED PANCREATIC CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
    Koom, Woong Sub
    Seong, Jinsil
    Kim, Yong Bae
    Pyun, Hae Ok
    Song, Si Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1148 - 1154
  • [3] CA 19-9 as a predictor for the response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy
    Koom, W.
    Seong, J.
    Kim, Y.
    Pyun, H.
    Song, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S261 - S262
  • [4] CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer
    Ishii, H
    Okada, S
    Sato, T
    Wakasugi, H
    Saisho, H
    Furuse, J
    Ishikawa, O
    Matsuno, S
    Yokoyama, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (13) : 279 - 283
  • [5] CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer
    Nakai, Yousuke
    Kawabe, Takao
    Isayama, Hiroyuki
    Sasaki, Takashi
    Yagioka, Hiroshi
    Yashima, Yoko
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Hirano, Kenji
    Sasahira, Naoki
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    ONCOLOGY, 2008, 75 (1-2) : 120 - 126
  • [6] Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
    Stephanie E. Combs
    Daniel Habermehl
    Kerstin A. Kessel
    Frank Bergmann
    Jens Werner
    Patrick Naumann
    Dirk Jäger
    Markus W. Büchler
    Jürgen Debus
    Annals of Surgical Oncology, 2014, 21 : 2801 - 2807
  • [7] Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
    Combs, Stephanie E.
    Habermehl, Daniel
    Kessel, Kerstin A.
    Bergmann, Frank
    Werner, Jens
    Naumann, Patrick
    Jaeger, Dirk
    Buechler, Markus W.
    Debus, Juergen
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (08) : 2801 - 2807
  • [8] Exploring the role of CA 19-9 level as a predictor of survival in patients with advanced pancreatic adenocarcinoma
    Bekaii-Saab, T.
    Majumber, A.
    Trolli, E.
    Thomas, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [9] Ca 19-9 can predict early response in patients (PTS) with advanced pancreatic cancer (PC)
    Berardi, Rossana
    Squadroni, Michela
    Scartozzi, Mario
    Silva, Rosa Rita
    Mari, Davide
    Massacesi, Cristian
    Pierantoni, Chiara
    Cascinu, Stefano
    ANNALS OF ONCOLOGY, 2006, 17 : 323 - 323
  • [10] Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9
    Kim, Seung-Seob
    Lee, Sunyoung
    Lee, Hee Seung
    Bang, Seungmin
    Han, Kyunghwa
    Park, Mi-Suk
    RADIOLOGY, 2022, 303 (03) : 548 - 556
12345